Home LiteratureArticle Details
PMID: 7255704 Published · ppublish English Case Reports Journal Article

"Semi-invasive" pulmonary aspergillosis: a new look at the spectrum of aspergillus infections of the lung.

Radiology ·Vol. 140 ·No. 2 ·1981-08-00 ·Pages 313-21

Gefter WB, Weingrad TR, Epstein DM, Ochs RH, Miller WT

Abstract

A chronic cavitary form of pulmonary aspergillosis may occur with mild immunosuppression or underlying lung disease. In this "semi-invasive" type, the fungus is intermediate between a simple saprophyte and an invasive pathogen. Aspergillus may produce extensive lung destruction despite the lack of vascular invasion. The absence of a previous cavity distinguishes such cases from secondary noninvasive mycetomas. Radiographic features include a chronic infiltrate, progressive cavitation, and subsequent mycetoma formation. Biopsy may be helpful; however, marked squamous metaplasia can produce false-positive Class V cytological findings even though malignancy is excluded. This variety of aspergillosis supports the concept that the traditional allergic, saprophytic, and invasive forms may represent a spectrum of disease dependent on host immune status and lung architecture.

MeSH Terms
Aged Aspergillosis/classification,diagnostic imaging,etiology False Positive Reactions Female Humans Immunosuppression Therapy/adverse effects Male Middle Aged Pneumonia/diagnostic imaging,etiology Radiography
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Gefter W B
Weingrad T R
Epstein D M
Ochs R H
Miller W T
Article Info
Journal
Radiology
Abbr.
Radiology
ISSN
0033-8419
Published
1981-08-00
Pages
313-21
Language
English
Region
United States
NLM ID
0401260
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com